Sign in
8-K

Current Report

Protalix BioTherapeutics, Inc. Filed Acc 0001144204-15-067493

Regulation FD disclosure

  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading v425463_8k.htm…